CBT Plus SMC Compared to SMC for Persistent Physical Symptoms in Secondary Care (PRINCE)

计划入组 324 人 · 首次发布于 2015 年 4 月 27 日

Renal Allograft Tolerance Through Mixed Chimerism - SMC/MGH

计划入组 20 人 · 首次发布于 2020 年 9 月 7 日

SMC Radiation Oncology SABR Cohort for Oligometastasis

计划入组 60 人 · 首次发布于 2025 年 8 月 13 日

SMC-107

SMC-103

SMC-3176

SMC CO., LTD.

Japan

Abbott Laboratories

United States

Concordia Laboratories Inc.

Luxembourg

Leronlimab Shows Promise in Reversing Liver Fibrosis in Preclinical MASH Study

CytoDyn Appoints Dr. Melissa Palmer as Hepatology Lead and Advances Leronlimab Studies for MASH and Liver Fibrosis

Leronlimab Shows Promising Results in Reversing Liver Fibrosis, CytoDyn Reports